{rfName}
Th

Indexed in

License and use

Icono OpenAccess

Altmetrics

Analysis of institutional authors

Bousquet JAuthorSarquis Serpa FAuthorDa Silva JAuthorLarenas-Linnemann DAuthorBurguete Cabañas MtAuthorMösges RAuthorPrice DAuthorAntó JmAuthor

Share

October 22, 2017
Publications
>
Article

The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study.

Publicated to:Allergy. 73 (2): 505-510 - 2018-02-01 73(2), DOI: 10.1111/all.13307

Authors: Bousquet J, Arnavielhe S, Bedbrook A, Fonseca J, Morais Almeida M, Todo Bom A, Annesi-Maesano I, Caimmi D, Demoly P, Devillier P, Siroux V, Menditto E, Passalacqua G, Stellato C, Ventura MT, Cruz AA, Sarquis Serpa F, da Silva J, Larenas-Linnemann D, Rodriguez Gonzalez M, Burguete Cabañas MT, Bergmann KC, Keil T, Klimek L, Mösges R, Shamai S, Zuberbier T, Bewick M, Price D, Ryan D, Sheikh A, Anto JM, Mullol J, Valero A, Haahtela T, Valovirta E, Fokkens WJ, Kuna P, Samolinski B, Bindslev-Jensen C, Eller E, Bosnic-Anticevich S, O'Hehir RE, Tomazic PV, Yorgancioglu A, Gemicioglu B, Bachert C, Hellings PW, Kull I, Melén E, Wickman M, van Eerd M, De Vries G, MASK study group

Affiliations

Acad Med Ctr, Dept Otorhinolaryngol, Amsterdam, Netherlands      University of Amsterdam    Academic Medical Center Amsterdam - Author
Asthma Reference Ctr, Escola Super Ciencias Santa Casa Misericordia Vit, Vitoria, Spain       - Author
Celal Bayar Univ, Dept Pulmonol, Manisa, Turkey      Celal Bayar University       - Author
Charite, Comprehens Allergy Ctr Charite, Dept Dermatol & Allergy, Berlin, Germany      Charite Medical University of Berlin    Humboldt University of Berlin    Free University of Berlin       - Author
Charite, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany      Charite Medical University of Berlin    Free University of Berlin    Humboldt University of Berlin - Author
CIBERESP, Barcelona, Spain      CIBERESP    CIBER - Centro de Investigacion Biomedica en Red - Author
Ctr Med Zambrano Hellion, Monterrey, Mexico - Author
Ctr Res Environm Epidemiol CREAL, ISGlobal, Barcelona, Spain      ISGlobal    Pompeu Fabra University - Author
Ctr Rhinol & Allergol, Wiesbaden, Germany - Author
CUF Descobertas Hosp, Allergy Ctr, Lisbon, Portugal - Author
CUF Porto Inst & Hosp, Allergy Unit, Oporto, Portugal       - Author
Fed Univ Santa Catarina HU UFSC, Univ Hosp, Allergy Serv, Florianopolis, SC, Brazil       - Author
GARD Execut Comm, Manisa, Turkey - Author
Ghent Univ Hosp, ENT Dept, Upper Airways Res Lab, Ghent, Belgium      Ghent University Hospital    Ghent University - Author
Global Allergy & Asthma European Network GA2LEN, Berlin, Germany - Author
Helsinki Univ Hosp, Skin & Allergy Hosp, Helsinki, Finland      Helsinki University Central Hospital    University of Helsinki - Author
Hosp Angeles Pedregal, Pediat Allergy & Clin Immunol, Mexico City, DF, Mexico       - Author
Hosp del Mar, Res Inst, IMIM, Barcelona, Spain      Institut Hospital del Mar d'Investigacions Mediques (IMIM)    Hospital del Mar - Author
Hosp Med Sur, Ctr Excellence Asthma & Allergy, Mexico City, DF, Mexico       - Author
Humanitas Univ, Humanitas Res Hosp, Personalized Med Clin Asthma & Allergy, Milan, Italy      Humanitas University - Author
INSERM, EPAR U707, Paris, France      Institut National de la Sante et de la Recherche Medicale (Inserm) - Author
INSERM, U 1168, VIMA Ageing & Chron Dis Epidemiol & Publ Hlth App, Villejuif, France      Institut National de la Sante et de la Recherche Medicale (Inserm) - Author
iQ4U Consultants Ltd, London, England       - Author
Istanbul Univ, Dept Pulm Dis, Cerrahpasa Fac Med, Istanbul, Turkey      Istanbul University - Cerrahpasa    Istanbul University - Author
Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Clin Immunol, Leuven, Belgium      KU Leuven - Author
Kyomed, Montpellier, France - Author
MACVIA France, Contre Malad Chron Vieillissement Actif France, European Innovat Partnership Active & Hlth Ageing, Montpellier, France.      Universite de Montpellier - Author
MACVIA France, Contre Malad Chron Vieillissement Actif France, European Innovat Partnership Active & Hlth Ageing, Montpellier, France      Universite de Montpellier - Author
Med Univ Graz, Dept ENT, Graz, Austria      Medical University of Graz - Author
Med Univ Lodz, Barlicki Univ Hosp, Div Internal Med Asthma & Allergy, Lodz, Poland      Medical University Lodz - Author
Med Univ Warsaw, Dept Prevent Environm Hazards & Allergol, Warsaw, Poland      Medical University of Warsaw - Author
Monash Univ, Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia      Florey Institute of Neuroscience & Mental Health    Monash University - Author
Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia      Monash University - Author
Monash Univ, Dept Immunol, Melbourne, Vic, Australia      Monash University - Author
Observat & Pragmat Res Inst, Singapore, Singapore       - Author
Odense Univ Hosp, ORCA, Allergy Ctr, Odense, Denmark      Odense University Hospital - Author
Odense Univ Hosp, ORCA, Dept Dermatol, Odense, Denmark      Odense University Hospital - Author
Optimum Patient Care, Cambridge, England - Author
Paris VI, UPMC, EPAR UMR S, Paris, France      Sorbonne Universite - Author
Peercode DV, Gerdermalsen, Netherlands - Author
Soder Sjukhuset, Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden      Sodersjukhuset Hospital    Karolinska Institutet - Author
Soder Sjukhuset, Karolinska Inst, Stockholm & Inst Environm Med, Sachs Children & Youth Hosp, Stockholm, Sweden      Sodersjukhuset Hospital    Karolinska Institutet       - Author
Sorbonne Univ, CHRU Montpellier, UPMC Paris 06, IPLESP,Equipe EPAR,UMR S 1136, Paris, France      CHU de Montpellier    Sorbonne Universite    Universite de Montpellier - Author
Univ Aberdeen, Acad Ctr Primary Care, Aberdeen, Scotland      University of Aberdeen - Author
Univ Barcelona, Hosp Clin, Pneumol & Allergy Dept, Clin & Expt Resp Immunoallergy,IDIBAPS,CIBERES, Barcelona, Spain      CIBERES    IDIBAPS    Hospital Clinic de Barcelona    University of Barcelona    CIBER - Centro de Investigacion Biomedica en Red - Author
Univ Bari, Sch Med, Unit Geriatr Immunoallergol, Bari, Italy      University of Bari - Author
Univ Coimbra, Ctr Hosp Univ Coimbra, Fac Med Imunoalergol, Coimbra, Portugal      Universidade de Coimbra    Centro Hospitalar e Universitario de Coimbra (CHUC) - Author
Univ Cologne, Inst Med Stat Informat & Epidemiol, Med Fac, Cologne, Germany      University of Cologne       - Author
Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland      University of Edinburgh - Author
Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Med Informat, Asthma UK Ctr Appl Res, Edinburgh, Midlothian, Scotland      University of Edinburgh - Author
Univ Fed Bahia, ProAR Nucleo Excelencia Asma, Brasil & GARD Execut Comm, Salvador, BA, Brazil      Universidade Federal da Bahia       - Author
Univ Grenoble Alpes, Univ Joseph Fourier, Team Environm Epidemiol Appl Reprod & Resp Hlth, INSERM,IAB,U 1209, Grenoble, France      Communaute Universite Grenoble Alpes    Universite Grenoble Alpes (UGA)    Institut National de la Sante et de la Recherche Medicale (Inserm) - Author
Univ Naples Federico II, Ctr Pharmacoecon, CIRFF, Naples, Italy      University of Naples Federico II - Author
Univ Pompeu Fabra, Barcelona, Spain      Pompeu Fabra University - Author
Univ Porto, Ctr Hlth Technol & Serv Res, CINTESIS, Fac Med, Oporto, Portugal      Universidade do Porto       - Author
Univ Salerno, Scuola Med Salernitana, Dept Med Surg & Dent, Salerno, Italy      University of Salerno - Author
Univ Sydney & Sydney Local Hlth Dist, Woolcock Inst Med Res, Glebe, NSW, Australia      University of Sydney    Woolcock Institute of Medical Research - Author
Univ Versailles St Quentin En Yvelines, UMR S 1168, Montigny Le Bretonneux, France      Universite Paris Saclay (ComUE)    Universite Paris Saclay    Universite de Versailles Saint-Quentin-En-Yvelines       - Author
Univ Versailles St Quentin, Hop Foch, Pole Malad Resp, Lab Pharmacol Resp UPRES EA220, Suresnes, France      Universite Paris Saclay (ComUE)    Universite de Versailles Saint-Quentin-En-Yvelines    Hospital Foch    Universite Paris Saclay - Author
Univ Wurzburg, Inst Clin Epidemiol & Biometry, Wurzburg, Germany      University of Wurzburg       - Author
See more

Abstract

Mobile technology has been used to appraise allergic rhinitis control, but more data are needed. To better assess the importance of mobile technologies in rhinitis control, the ARIA (Allergic Rhinitis and its Impact on Asthma) score ranging from 0 to 4 of the Allergy Diary was compared with EQ-5D (EuroQuol) and WPAI-AS (Work Productivity and Activity Impairment in allergy) in 1288 users in 18 countries. This study showed that quality-of-life data (EQ-5D visual analogue scale and WPA-IS Question 9) are similar in users without rhinitis and in those with mild rhinitis (scores 0-2). Users with a score of 3 or 4 had a significant impairment in quality-of-life questionnaires.© 2017 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Keywords

allergic rhinitis and its impact on asthmaeuroquolmacvia-aria sentinel networkwork productivity and activity impairment in allergyAllergic rhinitis and its impact on asthmaEuroquolMacvia-aria sentinel networkRhinitisWork productivity and activity impairment in allergy

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Allergy due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2018, it was in position 4/27, thus managing to position itself as a Q1 (Primer Cuartil), in the category Allergy.

From a relative perspective, and based on the normalized impact indicator calculated from World Citations provided by WoS (ESI, Clarivate), it yields a value for the citation normalization relative to the expected citation rate of: 2.99. This indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Weighted Average of Normalized Impact by the Scopus agency: 2.46 (source consulted: FECYT Feb 2024)
  • Field Citation Ratio (FCR) from Dimensions: 10.65 (source consulted: Dimensions Jul 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-07-07, the following number of citations:

  • WoS: 71
  • Scopus: 78
  • Europe PMC: 37

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-07:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 103.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 112 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 6.85.
  • The number of mentions on the social network Facebook: 3 (Altmetric).
  • The number of mentions on the social network X (formerly Twitter): 11 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Australia; Austria; Belgium; Brazil; Denmark; Finland; France; Germany; Italy; Mexico; Netherlands; Poland; Portugal; Singapore; Sweden; Turkey; United Kingdom.

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (REY CALERO, JUAN DEL) .